Basic Biological Overview of Eating Disorders

Katherine A. Halmi
Eating Disorders Program
Cornell Medical Center—Westchester Division
White Plains, New York 10605.


1. Anderson IM, Perry-Billings SM, Newsholme EA, et al. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med 1990;20:785–791.

2. Arase K, York DA, Chimizuh H. Effects of corticotropin releasing factor in food intake in brown adipose tissue thermogenesis in rats. Am J Physiol 1988;255:e255–e259.

3. Blouin AG, Blouin JH, Bratan JT, et al. Physiological and psychological responses to a glucose challenge in bulimia. Int J Eating Disord 1990;10:285–296.

4. Blundell JE, Hill AJ. Behavioral pharmacology of feeding: relevance of animal experiments in man. In: Carruba N, Blundell JE, eds. Pharmacology of eating disorders. New York: Raven Press, 1986; 51–70.

5. Blundell JE, Hill AJ. Nutrition, serotonin and appetite: case study in the evolution of a scientific idea. Appetite 1987;8:183–194.

6. Blundell JE, Latham M. Serotonergic influences on food intake: effect on 5-hydroxytryptophan on parameters of feeding behavior in deprived and free-feeding rats. Pharmacol Biochem Behav 1979;11:431–437.

7. Booth DA. How should questions about satiation be asked? Appetite 1981;2:237–244.

8. Booth DA. Food-conditioned eating preferences and aversions with interceptive elements: conditioned appetite and satieties. Ann NY Acad Sci 1985;443:22–41.

9. Brambilla F, Cavagnini F, Invitti C, et al. Neuroendocrine and psychopathological measures in anorexia nervosa: resemblances to primary affective disorders. Psychiatry Res 1985;16:165–176.

10. Brewerton TD, Lydiard RB, Laraia MT, et al. CSF beta-endorphins and dynorphin in bulimia nervosa. Am J Psychiatry 1992;149: 1086–1090.

11. Brewerton TD, Mueller ED, Lesem MD. Neuroendocrine responses to m-chlorophenol piperazine and L-tryptophan in bulimia. Arch Gen Psychiatr 1992;49:852–861.

12. Campfield LA, Brandan B, Smith FJ. Reduction in blood sugar before initiation of meals. Brain Res Bull 1985;14:605–616.

13. Casper RC, Pandy G, Jaspen JB, et al. Eating attitudes and glucose tolerance in anorexia nervosa patients at 8-year follow-up compared to control subjects. Psychiatry Res 1988;25:283–299.

14. Clark JT, Crawley WR, Kalra SP. Neuropeptide-Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984;115:427–429.

15. Crawley JN, Kiss JZ. Central control of CCK. Ann NY Acad Sci 1985;488:586–588.

16. Demitrack MA, Lesem MD, Listwak SJ, et al. CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiological considerations. Am J Psychiatry 1990;147:882–886.

17. Devlin MJ, Walsh T, Kral G, et al. Metabolic abnormalities in bulimia nervosa. Arch Gen Psychiatry 1990;47:144–148.

18. Fichter MM, Pirke KM, Pollinger J, et al. Disturbances in the hypothalamal–pituitary–adrenal and other neuroendocrine axes in bulimia. Biol Psychiatry 1990;27:1021–1037.

19. Fullerton DT, Swift WJ, Getto CJ, et al. Plasma immunoreactive b-endorphin in bulimics. Psychol Med 1986;16:59–63.

20. Fullerton DT, Swift WJ, Getto CJ, et al. Differences in the plasma b-endorphin levels of bulimics. Int J Eating Disord 1988;7:191–200.

21. Geracioti TD, Liddle RA. Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 1988;319:683–688.

22. Geracioti TD, Liddle RA, Altemus M, et al. Regulation of appetite and cholecystokinin secretion in anorexia nervosa. Am J Psychiatry 1992;149:958–961.

23. Gibbs J, Madison SP, Rolles ET. Bombesin and eating. J Comp Physiol Psychol 1981;85:1003–1015.

24. Glimcher P, Margolin D. Dopamine pathways. Brain Res 1986;266: 348–352.

25. Gold PW, Kaye WH, Robertson GL, et al. Abnormalities in plasma and cerebral spinal-fluid arginine vasopressin in patients with anorexia nervosa. N Engl J Med 1983;308:1117–1123.

26. Goldbloom DS, Zinman B, Hicks LK, et al. The baseline metabolic state in bulimia nervosa: abnormality and adaptation. Int J Eating Disord 1992;12:171–178.

27. Goodwin GM, Fairburn CG, Cowen PJ. Dieting changes serotonergic function in women but not men: implications for the etiology of anorexia nervosa? Psychol Med 1987;17:839–842.

28. Grossman SP. Eating behavior, the biology of motivation. Annu Rev Psychol 1979;30:209–242.

29. Gwirtsman HE, Kaye WH, George DT. Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia. Arch Gen Psychiatry 1989;46:61–69.

30. Halmi KA, Sunday SR. Temporal patterns of hunger and fullness ratings and related cognitions in anorexia and bulimia. Appetite 1991;16:219–237.

31. Halmi KA, Sunday SR. Macronutrient effects on eating behavior in anorexia and bulimia nervosa. SSIB, June 24–28, 1992. Princeton University, Princeton, NJ.

32. Halmi KA, Eckert E, LaDu T, Cohen J. Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 1986;43:177–181.

33. Halmi KA, Eckert E, Marchi PA, et al. Comorbidity of psychiatric diagnoses in anorexia nervosa. Arch Gen Psychiatry 1991;48:712–718.

34. Halmi KA, Owen WP, Lasley E, Stokes P. Dopaminergic regulation in anorexia nervosa. Int J Eating Disord 1983;21:192–233.

35. Halmi KA, Sunday SR, Puglisi A, Marchi PA. Hunger and satiety in anorexia and bulimia nervosa. In: Schnieder LH, Cooper SJ, Halmi KA, eds. The psychobiology of human eating disorders. New York: New York Academy of Sciences, 1989;431–445.

36. Heffner TG, Hartman JA, Seiden LS. Dopamine turnover in feeding. Science 1986;208:1168–1170.

37. Hill AJ, Magson LE, Blundell JE. Hunger and palatability: tracking ratings of selective experience before, during and after consumption of preferred and less preferred foods. Appetite 1984;8:361–371.

38. Hoebel BG. Pharmacological control with feeding. Annu Rev Pharmacol Toxicol 1977;17:605–621.

39. Hoebel BG. Hypothalamic self-stimulation and stimulation escape in relation to feeding and mating. Fed Proc 1979;30:2454–2461.

40. Hoebel BG. Neurotransmitters in the control of feeding and its rewards: monoamines, opiates, and brain–gut peptides. In: Stunkard AJ, Steller E, eds. Eating and its disorders. New York: Raven Press, 1984;15–38.

41. Hotta M, Chibasaki T, Masuda A, et al. The responses of plasma adrenal corticotropin and cortisol to corticotropin-releasing hormone and cerebral spinal fluid immunoreactive CRH in anorexia nervosa patients. J Clin Endocrinol Metab 1986;62:319–321.

42. Jhanvar-Uniyal M, Fleisher F, Levine BE. Alpha-adrenergic receptor binding in the lateral hypothalamus. Abstr Soc Neurosci 1982;8:711.

43. Jimerson DC, Lessem MD, Kaye WH, et al. Low serotonin and dopamine metabolite concentrations in cerebral spinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 1992;49:132–138.

44. Kaplan AS, Garfinkel PE, Walsh FC, et al. Clonedine challenge test in bulimia nervosa. Int J Eating Disord 1989;8:425–435.

45. Kaye WH, Berrettini W, Gwirtsman HE, et al. Altered cerebral spinal fluid neuropeptide-Y and peptide-YY immunoactivity in anorexia and bulimia nervosa. Arch Gen Psychiatry 1990;47:548–556.

46. Kaye WH, Ebert N, Gwirtsman HE, et al. Serotonin metabolism in anorexia nervosa. Am J Psychiatry 1984;41:1598–1601.

47. Kaye WH, Ebert MH, Gwirtsman HE, et al. CSF monoamine levels in normal weight bulimia & evidence for abnormal noradrenergic activity. Am J Psychiatry 1990;147:225–229.

48. Kaye WH, Ebert N, Raleigh M, et al. Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch Gen Psychiatry 1984;41:350–355.

49. Kaye WH, Gwirtsman HE, George DT. Elevated cerebral spinal fluid levels of immunoreactive corticotropin-releasing hormones in anorexia nervosa: relation to state of nutrition adrenal function, and intensity of depression. J Clin Endocrinol Metab 1987;64:203–208.

50. Kaye WH, Gwirtsman HE, George DT, et al. Altered serotonin activity in anorexia nervosa after long-term weight restoration. Arch Gen Psychiatry 1991;48:556–562.

51. Kaye WH, Pickar D, Naber D, et al. Cerebral spinal fluid opioid activity in anorexia nervosa. Am J Psychiatry 1982;139:643–645.

52. Kennedy SH, Garfinkel PE, Parienti V, et al. Changes in mellatonin levels but not cortisol levels are associated with depression in patients with eating disorders. Arch Gen Psychiatry 1989;46:73–78.

53. Leibowitz SF. Opioids and food selection. In: Morgan PG, Pankse PP, eds. Handbook of the hypothalamus, vol 3. New York: Marcel Dekker, 1982;299–437.

54. Leibowitz SF. Neurochemical systems of the hypothalamus: control of feeding and drinking behavior and water electrolyte excretion. In: Morgan PJ, Panksepp J, eds. Handbook of the Hypothalamus, vol 3. New York: Raven Press, 1987;130–150.

55. Leibowitz SF, Brown O, Trettor JE Jr, et al. Norepinephrine, clonidine and tricyclic antidepressants selectively stimulate carbohydrate ingestion through noradrenergic system of the paraventricular nucleus. Pharmacol Biochem Behav 1985;23:541–550.

56. Lessem MD, George DT, Kaye WH. State-related changes in norepinephrine regulation in anorexia nervosa. Biol Psychiatry 1989; 25:509–512.

57. Louis-Sylvester J, LeMagnen J. A new glucostatic hypothesis. Neurosci Biobehav Rev 1980;4:13–15.

58. Martin CF, Gibbs J. Bombesin effect on sham feeding. Peptides 1980;1:131–134.

59. McBride PA, Anderson GM, Khait V, Sunday SR, Halmi KA. Serotonergic responsivity in eating disorders. Psychopharmacol Bull 1991;27:365–372.

60. Mitchell JE, Christenson G, Jennings J, et al. A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal-weight bulimia. J Clin Pharmacol 1989;9:94–97.

61. Mitchell JE, Laine DE, Morley JE. Naloxone but not CCK-8 may attenuate binge eating in patients with bulimia syndrome. Biol Psychiatry 1986;21:1399–1406.

62. Morley JE, Levine AS, Grace M. Peptide-YY: a potent orexigenic agent. Brain Res 1985;340:200–203.

63. Morley JE, Levine AS. Corticotropin-releasing factor, grooming and ingestive behavior. Life Sci 1982;31:1459–1464.

64. Morley JE, Levine AS, Willenbirng NL. Stress induced feeding disorder. In: Carruba M, Blundell JE, eds. Pharmacology of Eating disorders. New York: Raven Press, 1986;71–100.

65. Mortola JF, Rasmussen BE, Yen SSC. Alterations of the adrenal corticotropin–cortisol axis in normal weight bulimic women: evidence for a central mechanism. J Clin Endocrinol Metab 1989; 68:517–522.

66. Nishita JK, Ellinwood EH, Rockwell WJK, et al. Abnormalities in the response of plasma argenine vasopressin during hypertonic salene fusion in patients with eating disorders. Biol Psychiatry 1989;26:73–86.

67. Pirke KM, Pahl J, Schweiger U, et al. Metabolic and endocrine indices of starvation in bulimia: a comparison with anorexia nervosa. Psychiatry Res 1985;15:33–39.

68. Rogers PJ, Blundell JE. Effect of anorectic drugs on food intake, and the micro-structure of eating in human subjects. Psychopharmacology 1979;66:159–165.

69. Rosmos DR, Gosnell BA, Morley JE. Effects of kappa opiate agonist cholescystokinin and bombesin on intake of diets varying in carbohydrate to fat ratio in rats. J Nutr 1987;117:976–985.

70. Silverstone T, Kyriakides M. Clinical pharmacology of appetite. In: Silverstone T, eds. Drugs and appetite, New York: Academic Press, 1982;50–65.

71. Strohmeyer AJ, Smith G. A sex difference in the effect of CCK on food and water intake in obese and lean mice. Peptides 1987;8:845–848.

72. Sunday SR, Halmi KA. Taste perceptions and hedonics in eating disorders. Physiol Behav 1990;48:587–594.

73. Sunday SR, Einhorn A, Halmi KA. The relationship of perceived macronutrient and caloric content to affective cognitions about food. Am J Clin Nutr 1992;55:362–371.

74. Vigersky RA, Loriaux DL, Anderson AE, et al. Anorexia nervosa: behavioral and hypothalamic aspects. Clin Endocrinol Metab 1976;5:517–535.

75. Waller DS, Kiser RS, Hardy BW, et al. Eating behavior in plasma b-endorphin in bulimia. Am Clin Nutr 1986;44:20–23.

76. Walsh BT, Roose SP, Katz JL, et al. Hypothalamic–pituitary–adrenal cortical activity in anorexia nervosa and bulimia. Psychoneuroendocrinology 1987;12:131–140.

77. West BE, Fay ED, Woods CS. Cholescystokinin consistently suppresses meal sites but not food intake in free-feeding rats. Am J Physiol 1984;246:776–787.

78. Wise RA, Spindler J, DWit H, Gerber GJ. Sub-stimulation behaviors. Science 1978;201:262–264.

79. Wurtman JJ, Wurtman RJ. Drugs that enhance central serotonergic transmission diminish elective carbohydrate consumption by rats. Life Sci 1979;24:895–903.

80. Young RC, Gibbs J, Anton J, et al. Sham feeding. J Comp Physiol Psychol 1974;87:795–800.

Back to Chapter

published 2000